GNSC-001

N/A

Report date: 2026/04/08 15:32:35

Base Information

Drug NameGNSC-001
Drug Alias NameAAVIL-1RaIL-1Rasc-rAAV2.5IL-1RaGNSC-001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesGenascence CorpNational Center For Advancing Translational SciencesMayo Clinic
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, KneeOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A